in the amount of THB 300 million • Trade and Other Current Receivables - Others decreased by THB 159.65 million from those as at December 31, 2019 to THB 110.44 million as a result of collection of the

Capital Structure As at 31 March 2019, the Company reported total assets of THB 62,978m, an increase of THB 4,048m from 31 December 2018, including THB 22,227m Current assets and THB 40,751m Non-current

total assets of THB 61,932m, an increase of THB 3,002m from 31 December 2018, including THB 20,714m Current assets and THB 41,218m Non-current assets. Total liabilities stood at THB 42,015m while interest

and services 82.2 156.4 (74.2) (47.4%) Other Current Assets 201.9 150.8 51.1 33.9% Right of Use Assets 23.6 - 23.6 100.0% Total Assets 6,698.0 5,728.6 969.4 16.9% Assets As of March 31, 2020, the

current assets 164.5 130.6 33.9 26.0 Equipment for lease 217.4 88.7 128.7 145.1 Total Assets 6,578.3 6,429.2 149.1 2.3 Assets As of September 30, 2021, the Company’s total assets increased by 149.1 MB

-22 Q1-23 VS Q4-22 (MB) (MB) % Cash and cash equivalent 1,590.7 1,486.6 104.1 7.0 Inventories 938.2 882.7 55.5 6.3 Other current assets 273.9 203.1 70.8 34.9 Property, plant and equipment 218.2 96.2

by more efficient management of pharmaceutical supplies. Administrative Expenses During 9M17, administrative expenses increased by 14% yoy due mainly to the increase of headcounts and salary rate in

อร์ตี้ จำกัด (มหาชน) กรุณาระบุเงื่อนไขในการค้นหา ค้นหาบริษัท JP: JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JSP: บริษัท เจ. เอส. พี. พร็อพเพอร์ตี้ จำกัด (มหาชน)   ล้างเงื่อนไข

the expenses. Financial Position Analysis Unit : MB As at 31 March 2018 As at 31 December 2017 Change MB % Cash and cash equivalents 137.42 124.63 12.79 10.26 Current investment 260.65 252.71 7.94 3.14

adjustment of fair value of the dairy cattle in the subsidiaries. - Other assets were mostly cash and equivalent transactions to cash, deferred income tax assets, intangible assets and Other non-current assets